Icahn School of Medicine at Mount Sinai

On Target

Choosing and Validating Drug Targets with Human Genetics and AI

Planned for

View program

About the symposium

Choosing the right target is a central challenge in drug discovery. Clinical development can fail when a candidate does not show sufficient benefit or raises safety concerns. Research has found that drug programs with human genetic evidence linking their targets to disease are more likely to progress through clinical development.

Turning a genetic finding into a therapeutic opportunity requires researchers to identify the relevant gene, assess the evidence, and select models and experiments that can test the target. On Target brings together the Departments of Genetics and Genomic Sciences and Pharmacological Sciences at the Icahn School of Medicine at Mount Sinai to examine these decisions and the role of AI in informing them.

The full-day program will connect researchers, clinician-scientists and trainees through a keynote, an informal trainee discussion, and panels on Mount Sinai resources, target selection, experimental validation and drug repurposing. In From Pitch to Pilot, finalist teams will present project ideas for feedback and the opportunity to receive pilot funding.

Read the research on genetic evidence and clinical trial progression

From Pitch to Pilot

Finalist teams will pitch their ideas to an expert panel, which will provide feedback and award pilot funding to the projects with the most potential to move forward.

Learn about the pitches

Registration

Registration is not open yet. Check back for details.